![A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel)in client-owned dogs with atopic dermatitis - Vet Smart Bulário A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel)in client-owned dogs with atopic dermatitis - Vet Smart Bulário](https://parse.vetsmart.com.br/parse/files/XhI4EJ09WGTwlYIT8kpQDrsVEsCjwatFNHDHQOEi/vetsmart-contents_Documents_DC_Zoetis_DCABlindedRandomizedPlaceboTrialOclacitinibApoquelDogsDermatitis_img9.jpg)
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel)in client-owned dogs with atopic dermatitis - Vet Smart Bulário
![A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client‐owned dogs with atopic dermatitis - Moyaert - 2017 - Veterinary Dermatology - Wiley Online Library A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client‐owned dogs with atopic dermatitis - Moyaert - 2017 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c2b648d9-5638-48ca-9b59-07c522867245/vde12478-fig-0001-m.jpg)
A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client‐owned dogs with atopic dermatitis - Moyaert - 2017 - Veterinary Dermatology - Wiley Online Library
![A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aebd91a5-1b60-49db-9526-5f29f1d15f97/vde12088-fig-0003-m.jpg)
A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library
![A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client‐owned dogs - Little - 2015 - Veterinary Dermatology - Wiley Online Library A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client‐owned dogs - Little - 2015 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/98da659e-4522-4567-b9f8-f53d56eb06c1/vde12186-toc-0001-m.jpg?trick=1693213208094)
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client‐owned dogs - Little - 2015 - Veterinary Dermatology - Wiley Online Library
![A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a22af9e1-0632-47de-b0ec-6069140e11a3/vde12088-fig-0002-m.jpg)
A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library
![PDF) A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel (R)) in client-owned dogs with atopic dermatitis PDF) A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel (R)) in client-owned dogs with atopic dermatitis](https://i1.rgstatic.net/publication/260443433_A_blinded_randomized_placebo-controlled_trial_of_the_efficacy_and_safety_of_the_Janus_kinase_inhibitor_oclacitinib_Apoquel_R_in_client-owned_dogs_with_atopic_dermatitis/links/53fd8a150cf2364ccc08cbb2/largepreview.png)
PDF) A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel (R)) in client-owned dogs with atopic dermatitis
![A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e86e26cb-b7c8-4149-a991-9f3206693cf8/vde12088-fig-0004-m.jpg)
A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library
![A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis - Cosgrove - 2013 - Veterinary Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/70679d1f-691b-4fa5-8966-f13205f9b2c1/vde12088-fig-0001-m.jpg)